Skip to main content
Skip to main content
OMDA logo

Omada Health (OMDA) Stock Analysis

$21.20 -$0.64 (-2.93%) |Weak · 40
Bottom line: Split View — our Council read (46/100) and AI Score (40/100) broadly agree. Strongest single signal: Izzy Englander bullish.
MCap: $1.26B| Vol: 1.90M| Target: $23.50 (+10.8%)| 52-wk range: $10.28 – $26.91
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Omada Health (OMDA) trades at $21.20 with AI Score 40/100 (Grade C). Omada Health is a virtual-care provider focused on chronic condition management. Market cap: $1.26B, Sector: Healthcare.

Price as of Jul 23, 2026 · Last analyzed: May 7, 2026
Omada Health is a virtual-care provider focused on chronic condition management. The company offers clinically validated digital programs for cardiometabolic disease, musculoskeletal care, and behavioral health.

OMDA stock analysis for 2026: Analysts have set a consensus price target of $23.50 for Omada Health, suggesting 10.8% upside from the current price of $21.20. The AI MoonshotScore is 40/100, indicating a neutral outlook. Key factors: analyst coverage, AI-driven quantitative scoring.

Watch the OMDA film Every key number, told as a short cinematic story — just press play. ~2 min
Council Score · Weighted Average of 3 Disciplines
Split View 46/100 · C

OMDA: 2/3 scored disciplines lean bearish. Dominant signal: Izzy Englander bullish.

How is this calculated? →
MoonshotScore · Growth Potential · 40/100
Business Quality
Strong Is this a genuinely good business?
Financial Safety
Strong Could this blow up on me?
Valuation
Neutral Am I paying a fair price?
Growth Durability
Strong Is the growth real and likely to last?
Momentum
Strong Is the market already moving on this?
Legends Council · 5 Legends + Moon AI
Ray Dalio
Bullish
Ken Griffin
Bullish
Izzy Englander
Bullish
Seth Klarman
Neutral
Moon AI
Neutral
Munger's Mindset · Balance Sheet & Valuation
Financial Health
Weak
Margin of Safety
Fairly Valued
Council Score · Weighted Average of 3 Disciplines · See tabs for details →

Why this analysis is different

  • A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
  • An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
  • Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Omada Health (OMDA) Healthcare & Pipeline Overview

CEOSean Duffy
Employees849
HeadquartersSan Francisco, CA, US
IPO Year2025

Omada Health delivers virtual care programs for chronic conditions, distinguishing itself through clinically validated, digitally delivered interventions. Addressing cardiometabolic disease, musculoskeletal issues, and behavioral health, Omada operates in the expanding healthcare information services sector, leveraging technology to improve patient outcomes and access to care.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: May 7, 2026

What Is the Investment Thesis for OMDA?

As of May 7, 2026 — figures reflect the data available on that date.

Omada Health presents a compelling investment thesis centered on its position in the expanding virtual-care market and its focus on chronic condition management. With a gross margin of 65.5%, Omada demonstrates a strong ability to generate profit from its services. Key value drivers include the increasing adoption of virtual care, the rising prevalence of chronic diseases, and Omada's ability to deliver clinically validated programs that improve patient outcomes and reduce healthcare costs. The company's partnerships with employers and health plans provide a stable revenue stream and opportunities for further expansion. The beta of 1.33 suggests higher volatility compared to the market. Growth catalysts include expanding into new therapeutic areas, increasing market penetration, and forming strategic partnerships. Potential risks include competition from other virtual-care providers, regulatory changes, and the need to continuously demonstrate the effectiveness of its programs.

Based on FMP financials and quantitative analysis

OMDA Key Highlights

  • Market Cap of $1.26B reflects Omada Health's valuation in the virtual care market.
  • Gross Margin of 65.5% indicates strong profitability in delivering virtual care services.
  • Profit Margin of -4.9% suggests the company is still investing in growth and expansion.
  • Beta of 1.33 indicates higher volatility compared to the market, potentially due to its growth stage.
  • Focus on chronic conditions aligns with the increasing prevalence of these diseases and the growing demand for virtual care solutions.

Who Are OMDA's Competitors?

OMDA is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
TDOC Teladoc Health, Inc. $8.66 -2.91% $1.56B
AMWL American Well Corporation (AMWL) $10.77 -7.63% $180M
NUTX Nutex Health, Inc. $153.56 -2.32% $914M 94
OMCL Omnicell, Inc. $40.86 -2.32% $1.86B 82
HSTM HealthStream, Inc. $26.39 -1.86% $771M 91
PGNY Progyny, Inc. $30.70 -2.07% $2.40B 95
RSLBF RaySearch Laboratories AB (publ) $18.85 +0.00% $640M 57
PHR Phreesia, Inc. $9.80 -2.10% $606M 55

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are OMDA's Key Strengths?

  • Clinically validated programs
  • Established partnerships with employers and health plans
  • Data-driven insights and personalized approach
  • Comprehensive virtual-care platform

What Are OMDA's Weaknesses?

  • Profit Margin is negative
  • Reliance on partnerships for revenue
  • Competition from established healthcare providers and digital health companies
  • Limited brand recognition compared to larger players

What Could Drive OMDA Stock Higher?

  • Expansion into new therapeutic areas, such as women's health or dermatology, to broaden the company's addressable market.
  • Increased adoption of virtual care by employers and health plans, driven by the need to reduce healthcare costs and improve access to care.
  • New clinical data demonstrating the effectiveness of Omada's programs in improving patient outcomes and reducing healthcare costs (expected Q4 2026).
  • Strategic partnerships with other healthcare providers and technology companies to expand Omada's capabilities and market reach.

What Are the Key Risks for OMDA?

  • Negative return on equity (-2.8%) — the business is not currently generating profit on shareholder capital.
  • Increased competition from other virtual-care providers, including established healthcare companies and emerging digital health startups.
  • Regulatory changes and healthcare policy that could impact the reimbursement of virtual-care services.
  • Data security and privacy breaches that could damage Omada's reputation and lead to legal liabilities.
  • The need to continuously demonstrate the effectiveness of Omada's programs in improving patient outcomes and reducing healthcare costs.

What Are the Growth Opportunities for OMDA?

  • Expansion into New Therapeutic Areas: Omada Health has the opportunity to expand its virtual-care programs into new therapeutic areas beyond its current focus on cardiometabolic disease, musculoskeletal care, and behavioral health. This could include areas such as dermatology, women's health, or oncology. The market for virtual specialty care is estimated to reach $75 billion by 2030, presenting a significant growth opportunity for Omada. By leveraging its existing platform and expertise, Omada can efficiently launch new programs and attract new customers.
  • Increased Market Penetration: Omada Health can increase its market penetration by expanding its partnerships with employers, health plans, and health systems. The company can target new customer segments, such as small and medium-sized businesses, or expand its reach within existing customer accounts. The market for virtual chronic condition management is estimated to reach $40 billion by 2027, providing ample opportunity for Omada to grow its customer base and revenue.
  • Strategic Partnerships and Acquisitions: Omada Health can pursue strategic partnerships and acquisitions to expand its capabilities and market reach. This could include partnering with other digital health companies, acquiring complementary technologies, or expanding into new geographic markets. Strategic partnerships can provide access to new customers, technologies, and expertise, while acquisitions can accelerate growth and expand Omada's product offerings.
  • International Expansion: Omada Health has the opportunity to expand its virtual-care programs into international markets. The demand for virtual care is growing globally, driven by factors such as increasing healthcare costs, aging populations, and the growing adoption of technology. By adapting its programs to meet the needs of different markets, Omada can tap into new sources of revenue and growth. The global virtual care market is expected to reach $55 billion by 2027.
  • Data-Driven Personalization: Omada Health can further leverage its data and analytics capabilities to personalize its programs and improve patient outcomes. By analyzing patient data, Omada can identify individual needs and preferences and tailor its programs accordingly. This can lead to improved engagement, adherence, and ultimately, better health outcomes. The market for personalized medicine is estimated to reach $3.5 billion by 2025, highlighting the growing importance of data-driven personalization in healthcare.

What Opportunities Does OMDA Have?

  • Expansion into new therapeutic areas
  • Increased market penetration through new partnerships
  • International expansion
  • Strategic acquisitions and partnerships

What Threats Does OMDA Face?

  • Regulatory changes and healthcare policy
  • Competition from other virtual-care providers
  • Data security and privacy concerns
  • Need to continuously demonstrate program effectiveness

What Are OMDA's Competitive Advantages?

  • Clinically Validated Programs: Omada's programs are backed by clinical evidence, demonstrating their effectiveness in improving patient outcomes.
  • Established Partnerships: Omada has established partnerships with major employers, health plans, and health systems, providing a stable revenue stream and a competitive advantage.
  • Data-Driven Insights: Omada leverages data and analytics to personalize its programs and improve patient engagement and outcomes.
  • Integrated Platform: Omada's platform integrates personalized coaching, connected devices, and data-driven insights, providing a comprehensive virtual-care solution.

What Does OMDA Do?

Omada Health, founded with the mission to transform healthcare through technology, is a virtual-care provider based in the United States. The company focuses on delivering clinically validated programs for individuals managing chronic conditions. These programs, offered digitally between traditional doctor visits, address critical areas such as cardiometabolic disease (including diabetes and heart health), musculoskeletal care, and behavioral health. Omada's approach integrates personalized coaching, connected devices, and data-driven insights to empower individuals to make sustainable lifestyle changes and improve their health outcomes. Since its inception, Omada Health has evolved from a diabetes-focused program to a comprehensive virtual-care platform addressing multiple chronic conditions. This expansion reflects the growing recognition of the interconnectedness of various health challenges and the need for integrated, holistic care. Omada partners with employers, health plans, and health systems to provide its programs to their members and patients. By leveraging technology, Omada aims to improve access to high-quality care, reduce healthcare costs, and enhance the overall patient experience. The company's commitment to clinical rigor and data-driven results has positioned it as a leader in the rapidly growing virtual-care market.

What Products and Services Does OMDA Offer?

  • Provides virtual care programs for chronic conditions.
  • Offers clinically validated programs for cardiometabolic disease.
  • Delivers digital interventions for musculoskeletal care.
  • Provides behavioral health support through virtual platforms.
  • Partners with employers, health plans, and health systems.
  • Uses personalized coaching and connected devices to improve patient outcomes.
  • Employs data-driven insights to empower individuals to make sustainable lifestyle changes.

How Does OMDA Make Money?

  • Generates revenue through contracts with employers, health plans, and health systems.
  • Charges fees for its virtual-care programs based on enrollment and engagement.
  • Offers subscription-based access to its platform and services.

What Industry Does OMDA Operate In?

Omada Health operates within the rapidly expanding healthcare information services industry, driven by the increasing adoption of virtual care and the growing prevalence of chronic diseases. The market is characterized by intense competition, with numerous players offering digital health solutions. Omada differentiates itself through its focus on clinically validated programs and its partnerships with employers and health plans. The industry is expected to continue to grow rapidly, fueled by technological advancements, increasing healthcare costs, and the growing demand for convenient and accessible care. Omada is well-positioned to capitalize on these trends, but faces challenges from established healthcare providers and emerging digital health companies.

Who Are OMDA's Key Customers?

  • Employers seeking to improve the health and productivity of their employees.
  • Health plans looking to reduce healthcare costs and improve member outcomes.
  • Health systems aiming to expand access to care and improve patient satisfaction.
AI Confidence: 73% Updated: May 7, 2026

ROE -3%Key Financial Metrics

Return on equity for Omada Health stands at -2.8%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -2.1%, showing how much profit it generates from its asset base. Its free cash flow yield is 1.5%, a gauge of the cash the business throws off relative to its market value. A current ratio of 3.92 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -0.5%, the inverse of the P/E and a quick read on earnings relative to price.

Omada Health (OMDA) Valuation Context

Valued at $1.26B, OMDA is classified as a small-cap stock. Relative to its peer group, OMDA's quantitative score of 40/100 is below the peer average of 89/100.

Company Profile

Omada Health operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in San Francisco, US. The company is led by CEO Sean Duffy. OMDA has traded publicly since 2025.

F-Score 6/9Financial Health

Omada Health's Piotroski F-Score is 6/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 11.96 places it in the safe zone, indicating low near-term bankruptcy risk.

FY2026 estForward Outlook

Wall Street analysts project Omada Health revenue of about $328.0M for fiscal 2026, with EPS near $0.26. The estimate reflects 7 contributing analysts.

OMDA Financials

Fundamental Snapshot

Revenue Growth (FY)
+53.2%
Net Income Growth (FY)
+72.9%
EPS Growth (FY)
+74.1%
Free Cash Flow Growth (FY)
+144.5%
Return on Equity (TTM)
-2.8%
Current Ratio
3.9

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • Clinically validated programs
  • Established partnerships with employers and health plans
  • Data-driven insights and personalized approach
  • Comprehensive virtual-care platform

Bear Case

  • Profit Margin is negative
  • Reliance on partnerships for revenue
  • Competition from established healthcare providers and digital health companies
  • Limited brand recognition compared to larger players

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026

OMDA Latest News

OMDA Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for OMDA.

Price Targets

Consensus target: $23.50

OMDA MoonshotScore

40/100

What does this score mean?

The MoonshotScore rates OMDA 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.

Leadership: Sean Duffy

CEO

Sean Duffy is the CEO of Omada Health, leading the company's efforts to transform healthcare through virtual-care programs. He has a background in healthcare and technology, with experience in building and scaling innovative healthcare solutions. Prior to joining Omada Health, Sean held leadership positions at various healthcare companies, where he focused on improving patient outcomes and reducing healthcare costs. He brings a wealth of knowledge and expertise to Omada Health, driving the company's growth and innovation.

Track Record: Under Sean Duffy's leadership, Omada Health has expanded its virtual-care programs to address a wider range of chronic conditions and has established partnerships with major employers, health plans, and health systems. He has overseen the company's growth in market share and revenue, while maintaining a focus on clinical rigor and data-driven results. Sean has also led Omada Health through successful funding rounds, securing capital to fuel its continued expansion.

Omada Health Healthcare Stock: Key Questions Answered

What does the AI Score mean for OMDA?

OMDA holds an AI Score of 40/100 (Grade: C). This is an educational research signal, not a buy or sell recommendation. Omada Health is a virtual-care provider focused on chronic condition management. The company offers clinically validated digital programs for cardiometabolic disease, musculoskeletal care, …

What does Omada Health do?

Omada Health is a virtual-care provider that offers clinically validated programs for chronic conditions such as cardiometabolic disease, musculoskeletal care, and behavioral health. The company partners with employers, health plans, and health systems to provide its programs to their members and patients.

What do analysts say about OMDA stock?

As a private company, there is no publicly traded stock for Omada Health (OMDA). Therefore, there are no analyst ratings or price targets available. However, the company's performance and potential can be evaluated based on its market position, growth prospects, and financial metrics.

What are the main risks for OMDA?

Omada Health faces several risks, including increasing competition from other virtual-care providers, regulatory changes in the healthcare industry, and the need to continuously demonstrate the effectiveness of its programs. The virtual-care market is becoming increasingly crowded, with established healthcare companies and emerging digital health startups vying for market share.

What are the key factors to evaluate for OMDA?

Omada Health (OMDA) holds an AI score of 40/100 (low). Analysts target $23.50 (+11%). Not financial advice.

How frequently does OMDA data refresh on this page?

OMDA's price was last updated on Jul 23, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.

What has driven OMDA's recent stock price performance?

Omada Health (OMDA) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Clinically validated programs. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider OMDA overvalued or undervalued right now?

Omada Health (OMDA) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Analysts target $23.50 (+11%) — upside seen. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

How do I research OMDA before investing?

Before investing in Omada Health (OMDA), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Information is based on available data and may be subject to change.
  • Financial metrics are based on estimates and may not reflect actual performance.
Data Sources

Popular Stocks